Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study

MLA

Moon Soo Lee, et al. “Long-Term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: A Propensity Score-Matched Multicenter Cohort Study.” Journal of Gastric Cancer, vol. 20, no. 2, Mar. 2020, pp. 152–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a9e716791d52537d5cbf7937f6575b5c&authtype=sso&custid=ns315887.

APA

Moon Soo Lee, In Hwan Kim, Chang-Hyun Kim, Jae Seok Min, Chan Young Kim, Moon-Won Yoo, Ji-Ho Park, Sung Soo Kim, Young Gil Son, Sungho Jin, Kyung Won Seo, Sung Il Choi, Joong-Min Park, Kyung Ho Pak, Hoon Hur, Ye Seob Jee, Sang Eok Lee, Sung Jin Oh, Sun Hwi Hwang, … Chang Min Lee. (2020). Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study. Journal of Gastric Cancer, 20(2), 152–164.

Chicago

Moon Soo Lee, In Hwan Kim, Chang-Hyun Kim, Jae Seok Min, Chan Young Kim, Moon-Won Yoo, Ji-Ho Park, et al. 2020. “Long-Term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: A Propensity Score-Matched Multicenter Cohort Study.” Journal of Gastric Cancer 20 (2): 152–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a9e716791d52537d5cbf7937f6575b5c&authtype=sso&custid=ns315887.